121 related articles for article (PubMed ID: 9135505)
1. Pharmacokinetics and tolerance of vinorelbine in elderly patients with metastatic breast cancer.
Sorio R; Robieux I; Galligioni E; Freschi A; Colussi AM; Crivellari D; Saracchini S; Monfardini S
Eur J Cancer; 1997 Feb; 33(2):301-3. PubMed ID: 9135505
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of vinorelbine in patients with liver metastases.
Robieux I; Sorio R; Borsatti E; Cannizzaro R; Vitali V; Aita P; Freschi A; Galligioni E; Monfardini S
Clin Pharmacol Ther; 1996 Jan; 59(1):32-40. PubMed ID: 8549031
[TBL] [Abstract][Full Text] [Related]
3. Blood and plasma pharmacokinetics of vinorelbine in elderly patients with advanced metastatic cancer.
Gauvin A; Pinguet F; Culine S; Astre C; Cupissol D; Bressolle F
Cancer Chemother Pharmacol; 2002 Jan; 49(1):48-56. PubMed ID: 11855752
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetics of vinorelbine.
Levêque D; Jehl F
Clin Pharmacokinet; 1996 Sep; 31(3):184-97. PubMed ID: 8877249
[TBL] [Abstract][Full Text] [Related]
5. Bayesian estimate of vinorelbine pharmacokinetic parameters in elderly patients with advanced metastatic cancer.
Gauvin A; Pinguet F; Culine S; Astre C; Gomeni R; Bressolle F
Clin Cancer Res; 2000 Jul; 6(7):2690-5. PubMed ID: 10914711
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of short intravenous vinorelbine infusions in patients with metastatic breast cancer.
Deporte-Fety R; Simon N; Fumoleau P; Campone M; Kerbrat P; Bonneterre J; Fargeot P; Urien S
Cancer Chemother Pharmacol; 2004 Mar; 53(3):233-8. PubMed ID: 14634791
[TBL] [Abstract][Full Text] [Related]
7. Sensitive high-performance liquid chromatographic method with fluorescence detection for measurement of vinorelbine plasma concentrations.
Robieux I; Vitali V; Aita P; Freschi A; Lazzarini R; Sorio R
J Chromatogr B Biomed Appl; 1996 Jan; 675(1):183-7. PubMed ID: 8634764
[TBL] [Abstract][Full Text] [Related]
8. UFT/leucovorin plus vinorelbine combination for advanced breast cancer.
Fumoleau P; Déporte R; Kerbrat P; Bonneterre J; Fargeot P
Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):50-5. PubMed ID: 11098494
[TBL] [Abstract][Full Text] [Related]
9. Oral versus intravenous vinorelbine: clinical safety profile.
Gebbia V; Puozzo C
Expert Opin Drug Saf; 2005 Sep; 4(5):915-28. PubMed ID: 16111453
[TBL] [Abstract][Full Text] [Related]
10. Oral vinorelbine pharmacokinetics and absolute bioavailability study in patients with solid tumors.
Marty M; Fumoleau P; Adenis A; Rousseau Y; Merrouche Y; Robinet G; Senac I; Puozzo C
Ann Oncol; 2001 Nov; 12(11):1643-9. PubMed ID: 11822766
[TBL] [Abstract][Full Text] [Related]
11. [Oral vinorelbine: pharmacology and treatment outcome in non-small cell bronchial carcinoma and breast carcinoma].
Bartsch V
Onkologie; 2006 Mar; 29 Suppl 1():1-28. PubMed ID: 16534241
[TBL] [Abstract][Full Text] [Related]
12. Vinorelbine: an active, non cross-resistant drug in advanced breast cancer. Results from a phase II study.
Terenziani M; Demicheli R; Brambilla C; Ferrari L; Moliterni A; Zambetti M; Caraceni A; Martini C; Bonadonna G
Breast Cancer Res Treat; 1996; 39(3):285-91. PubMed ID: 8877008
[TBL] [Abstract][Full Text] [Related]
13. Non-small-cell lung cancer in elderly patients: influence of age on vinorelbine oral pharmacokinetics.
Puozzo C; Gridelli C
Clin Lung Cancer; 2004 Jan; 5(4):237-42. PubMed ID: 14967076
[TBL] [Abstract][Full Text] [Related]
14. Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer.
Livingston RB; Ellis GK; Gralow JR; Williams MA; White R; McGuirt C; Adamkiewicz BB; Long CA
J Clin Oncol; 1997 Apr; 15(4):1395-400. PubMed ID: 9193331
[TBL] [Abstract][Full Text] [Related]
15. Rapid and sensitive determination of vinorelbine in human plasma by liquid chromatography-tandem mass spectrometry and its pharmacokinetic application.
Qian J; Wang Y; Chang J; Zhang J; Wang J; Hu X
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Mar; 879(9-10):662-8. PubMed ID: 21342795
[TBL] [Abstract][Full Text] [Related]
16. Phase I trial of afatinib plus vinorelbine in Japanese patients with advanced solid tumors, including breast cancer.
Mukai H; Masuda N; Ishiguro H; Mitsuma A; Shibata T; Yamamura J; Toi M; Watabe A; Sarashina A; Uttenreuther-Fischer M; Ando Y
Cancer Chemother Pharmacol; 2015 Oct; 76(4):739-50. PubMed ID: 26254023
[TBL] [Abstract][Full Text] [Related]
17. Vinorelbine: an overview.
Johnson SA; Harper P; Hortobagyi GN; Pouillart P
Cancer Treat Rev; 1996 Mar; 22(2):127-42. PubMed ID: 8665565
[No Abstract] [Full Text] [Related]
18. High-performance liquid chromatographic determination of vinorelbine in human plasma and blood: application to a pharmacokinetic study.
Gauvin A; Pinguet F; Poujol S; Astre C; Bressolle F
J Chromatogr B Biomed Sci Appl; 2000 Oct; 748(2):389-99. PubMed ID: 11087081
[TBL] [Abstract][Full Text] [Related]
19. A sequence-dependent combination of docetaxel and vinorelbine: pharmacokinetic interactions.
Cattel L; Recalenda V; Airoldi M; Tagini V; Arpicco S; Brusa P; Bumma C
Farmaco; 2001 Oct; 56(10):779-84. PubMed ID: 11718271
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of vinorelbine administered by 96-hour infusion in patients with advanced breast carcinoma.
Ibrahim NK; Rahman Z; Valero V; Willey J; Theriault RL; Buzdar AU; Murray JL; Bast R; Hortobagyi GN
Cancer; 1999 Oct; 86(7):1251-7. PubMed ID: 10506711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
